There is a well‐established link between mismatch repair protein status, immune cell infiltrate particularly CD8+ cells, expression of immune checkpoint inhibitors, and immune escape of the tumour in CRC, and these factors have been the focus of investigation into the predicted efficacy of immunotherapy in this subset of CRCs [36]. Here, CD8A is linked to neoplasm.